Decoding the Future of Pharma: Why Electronic Patient Information (ePIL) is a Must-Have Standard
In the complex world of pharmaceuticals, standards aren’t just a formality, they’re the foundation of quality, safety, and trust. They are the important blueprints that guide everything from drug discovery and manufacturing (Good Manufacturing Practices—GMP) to global supply chain traceability.
But the industry is accelerating into a digital future, and with it, a new critical standard is taking center stage: the electronic Patient Information Leaflet (ePIL), often referred to as ePI.
The paper leaflet is a relic of the past—often tiny, easily lost, and instantly outdated. The future of patient communication is digital, dynamic, and instantly accessible.
5 Reasons Standards (and ePIL) are Non-Negotiable in Pharma Today
With more than 10 years of experience in InDesign automation and plugin development, we’ve built a reputation for excellence. Our solutions are powered by the InDesign SDK-based plugins and scripting, allowing us to tackle even the most complex automation challenges. We have deep expertise in:
1. Ensuring Unwavering Product Quality and Patient Safety Standards like ICH Q10 and GMP define the minimum benchmarks for safe production. When you digitise the Patient Information Leaflet, the same principle applies: the ePIL standard guarantees patients and healthcare professionals receive the most current, accurate, and readable safety information, instantly. This is a crucial defense against the inconsistencies and delays inherent in paper-based systems, ensuring that even the most recent safety update is communicated in real-time.
2. Supporting Seamless Regulatory Compliance Regulatory bodies such as the EMA and MHRA are driving the shift. The EMA’s successful ePI pilot, using the EU ePI Common Standard and FHIR (Fast Healthcare Interoperability Resources), has proven that the regulatory system is ready for a phased implementation. By adopting standards like the eCTD for submissions and the IDMP/SPOR initiatives for structured data, you ensure your digital product information is aligned with the legislative path being paved in major markets.
3. Driving Global Harmonisation The pharmaceutical market is global. ePIL adoption, supported by international working groups, is essential for international alignment. A standard digital format ensures a medicine developed in one country can be reviewed and distributed in another with fewer redundancies. This transition is already underway, with countries like Japan moving to paperless systems for prescribed medicines and the EU planning a voluntary adoption phase.
4. Facilitating Innovation and Digital Transformation The next era of pharma relies on cutting-edge technologies like AI, e-labeling, digital therapeutics, and blockchain (as explored by groups like the PharmaLedger Association). Standards are the guardrails that ensure these innovations are safe, interoperable, and ethical. For ePIL, this means creating a structured, data-rich document that can interact seamlessly with electronic health records and be personalized based on patient needs.
5. Streamlining Operational Efficiency and Building Trust Standards reduce duplication, simplify audits, and make training easier. For ePILs, the benefits are clear:
Faster Time-to-Market: Real-time digital updates bypass the costly, lengthy process of reprinting paper leaflets.
Environmental Sustainability: Eliminating billions of paper leaflets dramatically reduces the industry’s carbon and water footprint.
Superior Accessibility: ePILs offer adjustable font sizes, multilingual support, and screen-reader compatibility, ensuring that the elderly, visually impaired, and multilingual populations have equitable access—a core principle supported by patient advocacy groups.
The shift to electronic patient information is a critical evolution, but navigating the technical integration, regulatory divergence, and compliance hurdles can be a complex maze. At Vakils, with over two decades immersed in pharmaceutical artwork, regulatory labelling, and process automation, we offer end-to-end support tailored to your market and product portfolio. Our expertise goes beyond simply delivering compliant, high-quality ePIL solutions. We collaborate to influence best practices, embrace invention, and co-create the future of patient communication.
Reach out to us info@vakilspremedia.com to learn more about how we can help you automate your artwork management.
